Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•22/10/2026•16:05 ET
0
Key Highlights
- ➤Faeth (FTH) grants three employees options covering 17,000 shares
- ➤Options carry a $19.44-per-share exercise price
- ➤Awards vest over four years, subject to continued employee service
- ➤Options were issued under Faeth’s 2026 Inducement Plan
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced that the Compensation Committee of Faeth’s Board of Directors granted three new employees options to purchase an aggregate of 17,000 shares of the Company’s common stock in connection with their employment (collectively, the “Option Awards”). The Option Awards were granted effective October 19, 2026 pursuant to the Company’s 2026 Inducement Plan as a material inducement to the individuals entering employment with Faeth in accordance with Nasdaq Listing Rule 5635(c)(4).
Get started
Create a free account to read the full story.